中国药房2013，Vol.24Issue(4)：313-315,3.DOI:10.6039/j.issn.1001-0408.2013.04.09
2011年八省(自治区)基本药物招标采购未中标药品分析
Analysis of the Losing Bidding Drug in the Centralized Bidding of Essential Drugs in 8 Provinces and Autonomous Region in 2011
马建春 1夏恒 2沈勇刚 1陈吉生1
作者信息
- 1. 广东药学院附属第一医院药学部/广东药学院临床药学系,广州510080
- 2. 广东药学院中药学院,广州510006
- 折叠
摘要
Abstract
OBJECTIVE: To provide reference for the improvement of centralized bidding system of essential drugs. METHODS: The losing bidding drugs of centralized bidding of essential drugs in Shandong, Anhui, Jiangxi, Hubei, Hunan, Sichuan, Guangdong, Guangxi provinces or autonomous regions in 2011 were analyzed statistically in terms of types and dosage form. RESULTS: 44 dosage varieties and other 87 dosage forms in essential drug list (EDL) lost the bid in 8 provinces and autonomous regions in 2011; the top 3 losing bidding drugs were anti-parasitic disease drugs, cardiovascular system drugs and blood system drugs. CONCLUSION: Inappropriate EDL, clinical demanding less and little profits result in losing bidding. It is suggested to consummating centralized bidding system and refining the election criteria of essential drugs.关键词
基本药物/招标采购/药品品种/药品剂型Key words
Essential drugs/Centralized bidding/Drug varieties/Dosage form分类
医药卫生引用本文复制引用
马建春,夏恒,沈勇刚,陈吉生..2011年八省(自治区)基本药物招标采购未中标药品分析[J].中国药房,2013,24(4):313-315,3.
